Patents by Inventor Manuel Medina Hidalgo

Manuel Medina Hidalgo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ON01910.Na enhances chemotherapeutic agent activity in drug-resistant tumors
    Patent number: 9545418
    Abstract: The invention includes compositions and methods of treatment of cancers susceptible to treatment with nucleotide analog chemotherapeutic agent, including cancers in which nucleotide analog resistant tumors have developed, including identifying a subject having cancer susceptible to treatment with a nucleotide analog chemotherapeutic agent and a mitotic disruptor/polo-like kinase (Plk) pathway inhibitor to a subject; and monitoring the subject for a reduction of stabilization of at least one sign or symptom of cancer.
    Type: Grant
    Filed: February 17, 2015
    Date of Patent: January 17, 2017
    Assignee: The Johns Hopkins University
    Inventors: Antonio Jimeno, Manuel Medina Hidalgo
  • ON01910.Na ENHANCES CHEMOTHERAPEUTIC AGENT ACTIVITY IN DRUG-RESISTANT TUMORS
    Publication number: 20150209381
    Abstract: The invention includes compositions and methods of treatment of cancers susceptible to treatment with nucleotide analog chemotherapeutic agent, including cancers in which nucleotide analog resistant tumors have developed, including identifying a subject having cancer susceptible to treatment with a nucleotide analog chemotherapeutic agent and a mitotic disruptor/polo-like kinase (PIk) pathway inhibitor to a subject; and monitoring the subject for a reduction of stabilization of at least one sign or symptom of cancer.
    Type: Application
    Filed: February 17, 2015
    Publication date: July 30, 2015
    Inventors: Antonio Jimeno, Manuel Medina Hidalgo
  • ON01910.Na enhances chemotherapeutic agent activity in drug-resistant tumors
    Patent number: 8962614
    Abstract: The invention includes compositions and methods of treatment of cancers susceptible to treatment with nucleotide analog chemotherapeutic agent, including cancers in which nucleotide analog resistant tumors have developed, including identifying a subject having cancer susceptible to treatment with a nucleotide analog chemotherapeutic agent and a mitotic disruptor/polo-like kinase (Plk) pathway inhibitor to a subject; and monitoring the subject for a reduction or stabilization of at least one sign or symptom of cancer.
    Type: Grant
    Filed: April 17, 2008
    Date of Patent: February 24, 2015
    Assignee: The Johns Hopkins University
    Inventors: Antonio Jimeno, Manuel Medina Hidalgo
  • ON01910.Na ENHANCES CHEMOTHERAPEUTIC AGENT ACTIVITY IN DRUG-RESISTANT TUMORS
    Publication number: 20110201675
    Abstract: The invention includes compositions and methods of treatment of cancers susceptible to treatment with nucleotide analog chemotherapeutic agent, including cancers in which nucleotide analog resistant tumors have developed, including identifying a subject having cancer susceptible to treatment with a nucleotide analog chemotherapeutic agent and a mitotic disruptor/polo-like kinase (Plk) pathway inhibitor to a subject; and monitoring the subject for a reduction or stabilization of at least one sign or symptom of cancer.
    Type: Application
    Filed: April 17, 2008
    Publication date: August 18, 2011
    Applicant: THE JOHNS HOPKINS UNIVERSITY
    Inventors: Antonio Jimeno, Manuel Medina Hidalgo